| Followers | 20 |
| Posts | 7894 |
| Boards Moderated | 5 |
| Alias Born | 10/17/2022 |
Wednesday, June 25, 2025 8:05:59 AM
$CSDX Exclusive Investor Invitation – Discover the Future of Healthcare Innovation
📅 Thursday, June 26 | 🕐 12:30 PM EDT | 🌍 8:30 PM Dubai | 🇩🇪 6:30 PM Berlin
Join CS Diagnostics Corp. LIVE at the Small Cap Growth Virtual Investor Conference
🔬 Backed by Over 25 Years of International Healthcare Expertise.
📈 Publicly Listed on OTCQB – and Poised for Major Growth.
🏥 Trusted by World-Class Hospital Networks and Global Sports Giants.
At CS Diagnostics Corp., we’re not just another healthcare company—we are reshaping the diagnostics landscape. With over two decades of hands-on experience in global medical supply and diagnostics, we have earned the trust of industry leaders across both medicine and professional sports.
Now, we’re entering our next phase of scalable, international growth—and we want you to be part of it.
🎯 Why Should You Join This Live Event?
• Be the first to hear about our latest milestones and growth strategy
• Learn why top-tier hospitals and elite sports organizations rely on our solutions
• Discover how your investment could be part of a high-impact, high-return journey
• Connect directly with the team behind a publicly listed OTCQB healthcare innovator
🔗 Register now to secure your spot and be part of our success story:
[https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/4998796/cs-diagnostics-corp-otcqb-csdx ]
📅 Thursday, June 26 | 🕐 12:30 PM EDT | 🌍 8:30 PM Dubai | 🇩🇪 6:30 PM Berlin
Join CS Diagnostics Corp. LIVE at the Small Cap Growth Virtual Investor Conference
🔬 Backed by Over 25 Years of International Healthcare Expertise.
📈 Publicly Listed on OTCQB – and Poised for Major Growth.
🏥 Trusted by World-Class Hospital Networks and Global Sports Giants.
At CS Diagnostics Corp., we’re not just another healthcare company—we are reshaping the diagnostics landscape. With over two decades of hands-on experience in global medical supply and diagnostics, we have earned the trust of industry leaders across both medicine and professional sports.
Now, we’re entering our next phase of scalable, international growth—and we want you to be part of it.
🎯 Why Should You Join This Live Event?
• Be the first to hear about our latest milestones and growth strategy
• Learn why top-tier hospitals and elite sports organizations rely on our solutions
• Discover how your investment could be part of a high-impact, high-return journey
• Connect directly with the team behind a publicly listed OTCQB healthcare innovator
🔗 Register now to secure your spot and be part of our success story:
[https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/4998796/cs-diagnostics-corp-otcqb-csdx ]
Recent CSDX News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 10:02:11 AM
- Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 03/12/2026 04:05:23 PM
- CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH • GlobeNewswire Inc. • 02/11/2026 03:01:57 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 07:00:11 PM
- CS Group (OTCQB: CSDX) Secures Strategic Manufacturing Partnerships, Accelerating Global Commercial Launch of MEDUSA SDP Hygiene Products • GlobeNewswire Inc. • 01/29/2026 01:49:13 PM
- CS Group (OTCQB: CSDX) Announces Multi-Channel Sales Model, Global Logistics Partners, and Sustainable Innovation Roadmap for MEDUSA SDP • GlobeNewswire Inc. • 01/21/2026 03:22:05 PM
- Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 11/17/2025 01:57:47 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 08:06:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 06:11:22 PM
- CS Interpharm and CS Diagnostics Pharma Complete Conversion of Preferred Shares to Common Stock, Strengthening CSDX's Path to Consolidated Financial Reporting • ACCESS Newswire • 10/31/2025 03:35:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/09/2025 08:21:28 PM
- Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 09/09/2025 10:01:49 AM
- Form 10-12G - Registration of securities [Section 12(g)] • Edgar (US Regulatory) • 07/29/2025 07:06:35 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 07/24/2025 08:15:15 PM
- Form 10-12G - Registration of securities [Section 12(g)] • Edgar (US Regulatory) • 07/22/2025 12:47:53 PM
